Podcasts about CDC

There are many things that can impact your ability to become pregnant. In today's episode, I'm reviewing the top 10 things to consider if you are TTC.    1. Environmental Toxins. Avoid microwaving food in plastic containers or bottles. Always store food and glass or stainless steel containers. Million Marker offers a test to find out if you have in-body toxicity. 2. Chemicals in food and everyday products. Verify that the products you are using are chemical free. You can do that on https://www.ewg.org/ 3. Being sedentary. The CDC and American College of OBGYN, both recommend exercise in amounts of 150 minutes per week. Avoid over exercising, as low BMI can also cause fertility issues. 4. Food allergies or intolerances. Work with a nutritionist to find out if you have a food allergy or other food intolerance. You may also want to consider working with a specialist if you have PCOS or working with a nutritionist like Rohini Bajekal to help you manage PCOS if you have it. 5. Blocked Fallopian Tubes. Check with your doctor to find out if this is what may be causing you to have a hard time TTC. 6. THC and Cannabinoids can affect the motility of the fallopian tube and the receptors in the lining of the uterus. This makes embryo implantation harder and it might not happen as quickly as you would want. 7. Nicotine. Nicotine can affect the DNA and the egg in the sperm cells, and it can also affect a woman's fertility such that she could go potentially into menopause earlier. 8. Blaming birth control pills. Many people think that birth control pills "cause" infertility, but the truth is that because they regulate your period they may be masking the indicators of infertility. Make sure you get your hormone levels checked with your doctor every year to confirm your levels.  9. Ignoring biology. Every woman is born with a finite number of eggs, and if you want to wait to have kids until later in life, be sure and freeze your eggs when you are in your 20s.  10. Not getting enough sleep.    Listen on Dr. Aimee's website.   Curious about IVF? Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, March 9, 2026 at 4pm PST, where Dr. Aimee will explain IVF and egg freezing and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

In this week's podcast episode in the Nutrition After Breast Cancer: Just the Facts series, I bring up the study that sparked that concern. I don't ignore things like this. I don't pretend they don't exist. If there's research being talked about, I want you to know about it. But here are the actual facts. The study was done in mice. The mice were made to consume about 40% of their diet in olive oil. And the rest of their diet was an obesogenic, high-carbohydrate diet designed to promote weight gain and metabolic dysfunction. That is not a Mediterranean diet. That is not olive oil drizzled over vegetables and salmon. That is not real life. It was a laboratory model designed to stress metabolism. Context matters. Deeply.   Resources Mentioned: Guide to Essential Fatty Acids: https://www.thebreastcancerrecoverycoach.com/oil Episode #326 Simplifying Seed Oils and Fatty Acids After Breast Cancer https://www.thebreastcancerrecoverycoach.com/326   Work with Laura: https://www.thebreastcancerrecoverycoach.com/health      REFERENCES: Obesity and Low-Fat Diet History Trends in Obesity Among Adults in the United States, 2005 to 2014 (CDC) https://www.cdc.gov/mmwr/preview/mmwrhtml/su6001a15.htm Documents obesity prevalence: 15.0% (1976-1980), 23.3% (1988-1994) Adult Obesity Prevalence Maps (CDC) https://pmc.ncbi.nlm.nih.gov/articles/PMC9611578/ 30.9% obesity prevalence (1999-2000) Adult Obesity Prevalence, 2021-2023 (CDC) https://www.cdc.gov/nchs/products/databriefs/db508.htm Current obesity prevalence: 40.3% How the Ideology of Low Fat Conquered America https://pubmed.ncbi.nlm.nih.gov/18296750/ Historical analysis of the low-fat movement Heart Disease Mortality Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 (Ford et al., NEJM 2007) https://www.nejm.org/doi/full/10.1056/NEJMsa053935 ~51% decline in men, ~49% decline in women 47% from medical treatments, 44% from risk factor changes Obesity and diabetes offset gains by 8% and 10% Heart Disease Mortality in the United States, 1970 to 2022 https://www.ahajournals.org/doi/10.1161/JAHA.124.038644 89% decrease in heart attack deaths 81% increase in heart failure and other heart disease deaths Omega-3s, Inflammation, and Cancer Omega-6/Omega-3 Ratios and Modern Diets Ancestral ratios: 1:1 to 4:1 Modern Western diet: 15:1 to 20:1 Impact on eicosanoid metabolism and cellular inflammation DHA and Triple Negative Breast Cancer (Journal of Nutritional Biochemistry, 2019) DHA induced cell death in TNBC cells Mechanism: altered membrane composition, increased oxidative stress in cancer cells High-Fat Diets and TNBC Metastasis (Preclinical Studies) CD36-mediated fatty acid uptake in TNBC Oleic acid-rich diets promoting metastasis in mouse models Importance of tumor phenotype and metabolic flexibility   Let's Connect! If this episode helped you breathe a little easier, please share it with a friend or leave a review. Every share helps spread this message of hope, healing, and whole-person wellness.

Episode OverviewDrew Price of Master Class Angling returns to The Articulate Fly fly fishing podcast to deliver a season debrief from Lake Champlain and discuss the release of his debut book, Favorite Flies for Vermont: 50 Essential Patterns from Local Experts (Stackpole Books). For anglers curious about multi-species fly fishing in the Northeast or the fly patterns that actually produce on Vermont's diverse waters, this episode covers both with depth and specificity.The 2025 season on Champlain was defined by record-low water levels — a rarity that revealed structure Drew had never seen and produced drone footage that will inform future guiding. Bowfin fishing was among the best he's seen in years, and November lake trout fishing exceeded expectations, reflecting growing demand for Laker guide trips. Drew brings that same multi-species perspective to the book, which covers 53 patterns ranging from pragmatic brook trout dries and blue-line streamer patterns to bowfin, gar and bass flies — including Drew's own glow-in-the-dark Clouser Minnow variation for lake trout and Chocklett-influenced bowfin patterns he's adapted for Champlain conditions. The conversation also covers the production process in candid detail: Drew's self-directed macro fly photography, his phone-interview approach to wrangling 50-plus tiers across Vermont and the editorial relationship with Jay Nichols at Stackpole. The historical dimension is a highlight — patterns like the Governor Aiken Bucktail, the Spirit of Pittsford Mills and a tribute to the late Rhey Plumley place Vermont's fly fishing culture in a lineage that goes back to Mary Orvis Marbury's early commercial tying work in Manchester.Key TakeawaysHow a record-low water year on Lake Champlain exposed bottom structure and shifted Drew's understanding of fish-holding spots in ways that will pay off for seasons to come.Why Vermont fly tiers skew pragmatic — tying quickly and in volume over aesthetics — and why beat-up flies often outfish perfect ones.How to properly attribute pattern variations to their originators, and why that intellectual honesty matters for the sport's tying culture.When to expect outstanding lake trout fishing on Lake Champlain, with November emerging as a peak window for fly rod Lakers.Why Lake Champlain's combination of world-class bass fishing, exceptional bowfin populations (including multiple IGFA tippet-class records) and 88 resident species makes it an underappreciated destination for fly anglers.How Tom Rosenbauer's CDC Rabbit's Foot Emerger became a standout pattern in the book, and what the story behind its development reveals about matching emerger behavior in the surface film.Techniques & Gear CoveredThe episode touches on a range of techniques tied to Champlain's multi-species fishery rather than a single tactical deep dive. Sight fishing in the shallows — push-pole work targeting bowfin, gar and carp — is central to Drew's guiding approach, and several flies in the book were designed specifically for those conditions. For lake trout, Drew discusses his glow-in-the-dark Clouser Minnow variation, a deep-November pattern that he describes as producing an unmistakable visual trigger as the fly returns to the boat in the dark. Variations on Blane Chocklett's patterns adapted for bowfin fishing also feature in the book, illustrating how Game Changer-platform thinking has crossed over into the warm-water exotic-species world. The book's fly photography (all shot by Drew himself using a macro setup he developed during the writing process) includes both hyper-realistic imitative patterns — like Thomas Ames's emerging caddis, designed to capture a specific stage of insect emergence — and intentionally rough, high-production guide flies built for Vermont's blue-line brook trout water. The trolling application of the Governor Aiken Bucktail for landlocked salmon rounds out the technique coverage, reflecting the lake's migratory salmonid fishery that intensifies in fall.Locations & SpeciesThe episode centers on Lake Champlain and the broader Vermont fly fishing ecosystem, with the lake positioned as a legitimate destination fishery for bass, bowfin, lake trout, pike, gar, carp and landlocked salmon — as well as brown trout and brook trout in the tributary streams. Drew notes that Champlain has ranked among the top five bass lakes in the country according to Bassmaster for three decades, and that it holds records across IGFA tippet classes for bowfin. The book also addresses Vermont's blue-line brook trout fishery, acknowledging the state's honest limitations as a trout destination (no super-consistent hatches, less predictable than Pennsylvania or Colorado tailwaters) while pointing readers to the wild brook trout corridors that define summer fly fishing in Vermont. Historically notable waters referenced include Furnace Brook in Pittsford — President Eisenhower's favorite trout stream — and the Northeast Kingdom, the setting for an archival photo tied to the Governor Aiken Bucktail chapter. November is flagged as a particularly productive window for lake trout on fly, with record-low 2025 water conditions adding context for why structure knowledge carries outsized importance on Champlain.FAQ / Key Questions AnsweredWhat made the 2025 fishing season on Lake Champlain unusual?The lake hit near-record low water levels in 2025, a sharp contrast to the high-water years immediately prior. The low water exposed bottom structure Drew had never seen, allowing him to understand exactly why fish hold in certain locations. Drone footage from the season is now part of his ongoing location research.What types of flies are featured in Favorite Flies for Vermont?The book covers 53 patterns, with roughly 40 trout flies and the remainder targeting warm-water and exotic species including bowfin, gar and bass. Patterns range from simple Tenkara-style CDC dries to hyper-realistic emerger caddis imitations from Thomas Ames. Several historically significant Vermont patterns are included, such as the Governor Aiken Bucktail and the Spirit of Pittsford Mills dry fly, with full attribution and historical context for each.How does Drew Price approach pattern attribution in his book?Drew is deliberate about crediting the originators of any pattern he's adapted, even when his modifications are significant. Variations on Blane Chocklett's warm-water patterns and a riff on Bob Clouser's minnow design for lake trout are both attributed explicitly in the text. He extends the same standard to historical patterns, tracing variations back through the tying lineage rather than presenting adaptations as entirely original work.When is the best time to fish for lake trout on Lake Champlain with a fly?November stands out as the peak window, based on Drew's guide experience. The season saw strong late-year Laker fishing and a notable uptick in guided Laker trip requests, which Drew describes as a welcome surprise. A glow-in-the-dark Clouser Minnow variation is his go-to pattern for night-time and low-light Laker sessions on the lake.Why does Drew Price consider Lake Champlain an underrated fly fishing destination?Champlain holds 88 species, roughly 30 of which are realistic fly rod targets — Drew has personally caught 15 different species in a single day on fly. The lake consistently ranks among the top five bass lakes in the U.S. and has produced IGFA tippet-class records for bowfin across nearly all classes. Despite those credentials, it remains well below the radar of most traveling fly anglers, which Drew is actively trying to change through the book and continued guiding.SponsorsThanks to TroutRoutes for sponsoring this episode. Use ARTFLY20 to get 20% off of your TroutRoutes Pro membership.Related ContentS7, Ep 27 – Master Class Angling: The Art of Fishing Exotic Species with Drew PriceS7, Ep 8 – Fly Tying Mastery: Tim Cammisa's New Book and Euro Nymphing AdventuresS2, Ep 114 – All Things Game Changer with Blane ChocklettConnect with Our GuestFollow Master Class Angling on Instagram.Follow the ShowFollow The Articulate Fly on Facebook,

Send Zorba a message!Zorba shares his thoughts on what criteria and qualifications are crucial when choosing a new Surgeon General; and shares a story about talking to a young family about vaccines during a recent office visit.(Recorded February 26, 2026)Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

Heart disease is the leading cause of death — but it's also one of the most preventable conditions.  In this episode of The Exam Room, Dr. Neal Barnard joins Chuck Carroll to reveal the best foods for reversing heart disease, lowering cholesterol, and protecting your arteries naturally. Dr. Barnard breaks down the science behind oats, beans, walnuts, leafy greens, flaxseed, berries, and more — and explain how these foods help remove LDL cholesterol, improve endothelial function, and reduce inflammation. Can plaque really shrink? How fast can cholesterol levels drop? What should you eat if you've already had a heart attack? If you're serious about improving your cardiovascular health, this evidence-based conversation offers practical steps you can start today.

In "Somebody to Lean On," Dr. Osterholm and Chris Dall discuss vaccine updates including the FDA's back-and-forth on the Moderna vaccine, leadership shake-ups at institutions like the CDC, and the current state of measles in the US. Dr. Osterholm will also bring you a respiratory virus update, including current vaccine guidance for flu, COVID and RSV. Op-Ed: The FDA refused to review a flu vaccine, contrary to evidence. Now the agency reversed itself (CIDRAP) The State of US Vaccine Policy (CIDRAP and Unbiased Science)Dentists still write millions of prescriptions a year for an antibiotic with life-threatening risks (CIDRAP)  Resources for vaccine and public health advocacy: Voices for Vaccines Families Fighting Flu Vaccinate Your Family Shot@Life Medical Reserve Corps Learn more about the Vaccine Integrity Project MORE EPISODES       SUPPORT THIS PODCAST   Music: "Beauty Flow" Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 License

Millions of people struggle to become pregnant in the U.S. And in 2024, fertility rates reached a new low, according to CDC data. Women are also waiting longer to have kids, while a growing number are deciding to opt out entirely.That's part of the reason the Trump administration is pushing for a baby boom and promising to make in-vitro fertilization more accessible. Earlier this month, the administration's new discounted prescription drug website, TrumpRx, went live.But fertility treatments continue to be prohibitively expensive for many, with the average cumulative cost of IVF treatments reaching up to $60,000. That's according to FertilityIQ.Beyond the eye-popping price tag, the journey itself can be emotionally taxing. The stress is so great it's been compared to a cancer diagnosis and can bring feelings of shame and guilt. It can also be confusing trying to decipher the many doctors' appointments and medical jargon.We sit down with an expert panel to talk through the latest in fertility treatments, debunk some persistent myths, and answer your questions.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.To manage podcast ad preferences, review the links below:See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Support your health journey with our private practice! Explore comprehensive lab testing, functional assessments, and expert guidance for your wellness journey. Find exclusive offers for podcast listeners at nutritionwithjudy.com/podcast. _____Michael and I dive into how childhood trauma reshapes the nervous system, drives addiction, and contributes to chronic illness, mental health struggles, and even premature death. We break down the CDC's ACE (Adverse Childhood Experiences) score, including the powerful data showing that an ACE score is associated with losing years of life, and discuss why trauma may be the hidden driver behind inflammation, immune dysfunction, and chronic disease. Make sure to listen to the full interview to learn more.Michael Menard is an inventor, entrepreneur, and author who grew up as the second oldest of 14 children in Kankakee, Illinois, later discovering that he and his siblings experienced complex childhood trauma. As Vice President of Engineering at Johnson & Johnson, his 14 patents transformed global manufacturing, and his expertise has been sought by the United Nations, NASA, Coca-Cola, and Pfizer. He is the founder of United Against Childhood Trauma (UACT) and the bestselling author of multiple books, including The Kite That Couldn't Fly and Greater Than Gravity.We discuss the following: Who is Michael MenardTrauma's hidden death tollACEs defined by the CDCACE score shortens lifespanCortisol damages brain and bodyShame prevents trauma healingBuilding ACE 2.0 intensityWholeness and EMDR healingThe sacred first 60 daysThe Paradox of Childhood Trauma_____EPISODE RESOURCESUnited Against Childhood Trauma (UACT)WebsiteInstagramThe Kite That Couldn't Fly (Memoir)_____WEEKLY NEWSLETTER 

America's overdose crisis keeps changing shape.In recent years, provisional CDC data have shown a sharp national decline in overdose deaths — even as public officials warn the street drug supply remains volatile and some communities see signs of a rebound.That uncertainty is also reshaping the recovery world — especially around opioids. Some people find abstinence-based recovery works best. Others rely on medication-assisted treatment (MAT), using prescribed medicine like methadone or buprenorphine to stabilize a person and reduce the risk of relapse. But MAT has long divided the recovery community, fueling a stigma around a deceptively simple question: When is someone sober?In this encore episode of Us & Them, Trey Kay visits the Clarksburg Mission in Clarksburg, West Virginia — a Christian-centered recovery facility where people pursue different paths toward sobriety — and where debates about medication, morality, and survival are never abstract.

We're marking Rare Disease Month 2026 by highlighting the powerful story of Shanthi Hegde, a young patient advocate working to transform how bleeding disorders are understood, treated, and supported. This work is fueled by her own arduous journey with two rare bleeding disorders and immune dysregulatory syndrome, and an extended diagnostic odyssey marked by dismissal, underdiagnosis, and structural bias. “I was told many times by many providers that these disorders are not common in Indians and that my bruises were there just because I'm brown.” Admirably, Shanthi pushed past this mistreatment, advocated for her medical needs, and devoted herself to tackling a range of issues confronting rare disease patients from mental health access to affordable drug pricing to research equity. In this remarkable Year of the Zebra conversation with host Lindsey Smith, you'll also learn about: Shanti's work with the Hemophilia Federation of America; How gaps extend beyond treatment to include insurance coverage, provider training, and substance use care; What clinicians can do to improve the work they do with rare disease patients. Join us for a conversation that connects patient voice to system change, and explores what real equity for rare disease communities will require. Mentioned in this episode:Hemophilia Federation of AmericaShanthi's LinkedIn Profile If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

About this episode: The CDC has long collected and publicly reported data on infectious diseases, vaccination rates, overdose deaths, and other health topics. But in 2025, many of these datasets inexplicably went dark. In this episode: the importance of real-time data in implementing public health solutions and the potential consequences of these lapses in reporting. Guests: Janet Freilich, JD, is a professor at the Boston University School of Law. She writes and teaches in the areas of patent law, intellectual property, information law, and civil procedure. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Unexplained Pauses in Centers for Disease Control and Prevention Surveillance: Erosion of the Public Evidence Base for Health Policy—Annals of Internal Medicine Dozens of CDC vaccination databases have been frozen under RFK Jr.—Ars Technica The Changing CDC Website—Public Health On Call (February 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

The CDC has recognized connection as a core part of health and wellbeing. Our brains are wired for this. Change the wiring and the results may be harmful. 

As institutions like the NIH and CDC face challenges, many professionals find themselves at a crossroads, forced to pivot their research focus to secure funding while grappling with a loss of passion and purpose. But what if there's a better way? Join Kemi as she explores pivoting versus strategic framing. Learn the difference and how to choose.  Coming soon: Applications for the Get That Grant® April 2026 cohort will open to the waitlist. Join here: www.kemidoll.com/gtgwaitlist If you'd like to learn more foundational career navigation concepts for women of color in academic medicine and public health, sign up for our KD Coaching Foundations Series: www.kemidoll.com/foundations. Text Dr. Kemi directly.

(February 24, 2026) Amy King and Neil Saavedra join Bill for Handel on the News. Judge Aileen Cannon bars the release of special counsel report on President Trump’s handling of classified documents. CDC deputy director abruptly departs agency. Nick Reiner pleads not guilty in L.A. slayings of parents Rob and Michele Reiner. President Trump will deliver State of the Union today.See omnystudio.com/listener for privacy information.

We Like Shooting - Ep 651 This episode of We Like Shooting is brought to you by: C&G Holsters (Code: WLSISLIFE) Midwest Industries (Code: WLSISLIFE) Night Fision (Code: WLSISLIFE) Die Free Co. (Code: WLSISLIFE) Bowers Group (Code: WLS) Flatline Fiber Co (Code: WLS15) Second Call Defense Swampfox Optics Text Dear WLS or Reviews +1 743 500 2171  New Public Notes Page: https://dngrsfrdm.com/public/ GEAR CHAT Civet Arms Civet-12 Shotgun The Civet-12 is a semi-automatic 12-gauge shotgun from Civet Arms that blends design elements from the Saiga and Remington 870, featuring a gas-operated system with a 3-lug rotating bolt. It includes an adjustable gas system for reliability across various loads and a fixed magazine with 5+1 capacity. The shotgun emphasizes durability with a chrome-lined barrel and synthetic furniture. Note Cloud Defensive EPL Henry Repeating Arms Explorer Carbine Series Henry Repeating Arms has debuted the Explorer Carbine Series, a line of lever-action rifles chambered in .22 LR, .22 WMR, and .17 HMR. These carbines feature a 16.25-inch barrel, American walnut stock with laser-cut scalloping, and a compact design optimized for recreational shooting. The series emphasizes lightweight construction and classic Henry craftsmanship with modern aesthetic enhancements. Kinetic Blossom Magpie Handheld Electric Speed Loader (Nick) The Kinetic Blossom Magpie is a handheld electric speed loader designed for rapid magazine reloading of AR-15 pattern rifles. It utilizes an electric motor to drive rounds from a connected stripper clip or magazine into the target magazine at high speed. Demonstrated at SHOT 2026, it features a compact, ergonomic design for bench or field use. Note Gideon Optics Pebble BULLET POINTS Gemtech Nebula 5.7 Suppressor The Gemtech Nebula 5.7 is a dedicated suppressor designed specifically for 5.7x28mm firearms such as the FN Five-seveN pistol and P90 PDW. It features a stainless steel construction with a black Cerakote finish, direct-thread 1/2×28 mount, and is rated for full-auto fire. The suppressor measures 5.45 inches in length and weighs 8.9 ounces, optimized for minimal impact on handling. Streamlight PolyTac 1 Flashlight The Streamlight PolyTac 1 is a compact, polymer-bodied flashlight designed for law enforcement, military, and first responders, featuring a high-intensity LED with three output modes: high (275 lumens), low (11 lumens), and strobe. It utilizes a push-button tail switch for momentary or constant-on operation and is powered by two CR123A lithium batteries. The light is IPX7 waterproof rated and impact-resistant up to 2 meters, with a multi-function clip for versatile mounting. GUN FIGHTS No one stepped into the arena this week. WLS IS LIFESTYLE Note 2 new camorado colorways. THE ALLEY Note Kel-Tec are nasty thieving hobbitses? https://x.com/KelTecOfficial/status/2025919697896821096 GOING BALLISTIC Minnesota HF 2850: Advances Semi-Auto Firearm Ban with Warrantless Home Inspections (Savage) Minnesota House File 2850, advanced by Democrats, proposes banning many semi-automatic firearms and mandates warrantless home inspections for registered owners to ensure compliance. The bill targets rifles, shotguns, and pistols with specific features like pistol grips or folding stocks. It passed the House Public Safety Committee on a party-line vote. Justice Alito Rumored Retirement Impact on Second Amendment (Bearing Arms Analysis) (Savage) The article discusses rumors of Supreme Court Justice Samuel Alito retiring in 2026, potentially allowing President Trump to appoint a replacement and solidify a pro-Second Amendment majority. It highlights Alito's key opinions in cases like Bruen and Rahimi, emphasizing his role in advancing gun rights. A retirement would shift the Court's balance amid ongoing challenges to gun laws. Mexico's Strict Gun Laws Highlighted After Cartel Response to Leader's Killing (Savage) Following the killing of a cartel leader, Mexican cartels responded by distributing firearms to civilians, underscoring the ineffectiveness of Mexico's stringent gun control laws. The article details how only permitted citizens can legally purchase firearms from a single government store in Mexico City, with severe restrictions on calibers and quantities. This incident reveals the stark contrast between legal acquisition barriers and the armed capabilities of criminal organizations. West Virginia HB 5596: GOA-Backed Legislation to Restore Lawful Machine Gun Transfers (Savage) Gun Owners of America (GOA) supports West Virginia House Bill 5596, which aims to nullify federal restrictions on machine gun transfers under the National Firearms Act (NFA). The bill would authorize state law enforcement to process and approve lawful NFA transfers, including machine guns, suppressors, short-barreled rifles, and short-barreled shotguns. It seeks to restore Second Amendment rights impaired by federal overreach. CPRC Study on Transgender Representation in Active Shooting Attacks (United States) (Savage) A study by the Crime Prevention Research Center (CPRC) analyzed 1,022 active shooting attackers from 1958 to October 2024, finding that 0.11% identified as transgender, compared to 0.29% in the U.S. general population per CDC data. Among 173 attackers with known mental health histories, one was transgender. The study highlights underrepresentation of transgender individuals in these attacks relative to their population share. New Mexico House Bill 136 Fails in Committee, Blocking Proposed Gun Ban (Savage) New Mexico House Bill 136, which sought to ban commonly owned semiautomatic firearms, was defeated in the House Judiciary Committee on a 6-5 vote. Anti-gun advocates expressed frustration over the bill's failure despite Democratic majorities in the state legislature. The legislation targeted AR-15 style rifles and similar semiautomatics, drawing opposition from gun rights supporters. REVIEWS Review: Brassguy Jarhead 1 Star. Im glad WLS has turned into minimum of 30 min of advertising. This isnt Unleashed. Get your shit right. PS. Jeremy is a cunt. Review: JackB 5 Squares! We Like Shooting reminds me of the best carp recipe ever created. Aaron is the giant Asian carp that jumped into your boat as you were cruising down the river. He just kinda crashes the party and breaks shit, but it's funny so you roll with it. Jerambe is the filet knife you use to carefully make 2 slits along either side of the carp's spine. No need to gut or scale the carp because it's better if it's alive Nick is the manure you roll into 1″ diameter balls and carefully place into the slits you carved. He's kind of unorthodox, but when he starts talking you wanna see where it goes. Shawn is the oven you set to 171 degrees and place the food in for 3.5 – 4 hours. He provides the structure and energy for all the magic to happen. And finally, Savage1r is the trash can that you throw the carp in after scooping out the filling. Because the balls shit will be the best tasting part of any carp recipe. Before we let you go – JOIN GUN OWNERS OF AMERICA We'd love if you supported the show, join Agency 171 at agency171.com. Lot's of prizes, rewards and kick ass swag. No matter how tough your battle is today, we want you here fight with us tomorrow. Don't struggle in silence, you can contact the suicide prevention line by dialing 988 from your phone. Remember – Always prefer Dangerous Freedom over peaceful slavery. We'll see you next time! Nick – @busbuiltsystems | Bus Built Systems Jeremy – @ret_actual | Rivers Edge Tactical Aaron – @machinegun_moses Savage – @savage1r Shawn – @dangerousfreedomyt | @camorado.cam | Camorado

Infection control consultant Katherine West breaks down the latest HIV post-exposure prophylaxis (PEP) guidelines published in mid-2025. Highlighting key changes since the 2013 update, she explains the shift toward less toxic antiretroviral regimens, elimination of routine baseline lab testing for PEP, and new protocols for exposures involving patients with undetectable viral loads. West emphasizes the importance of expert follow-up care, clarifies who is responsible for source patient testing, and underscores the low risk of occupational HIV transmission. She also discusses challenges faced by emergency providers managing exposures outside regular occupational health hours and the role of 24/7 consultation services. The segment covers legal nuances, especially OSHA and state laws regarding HIV testing consent, and reiterates the CDC's push for routine HIV screening to aid in the national goal of ending the HIV epidemic by 2030.

In this headline-driven episode, Jonathan and Wendy unpack the mounting turbulence inside U.S. public health institutions — from the political fallout over glyphosate and mRNA flu vaccines to FDA reversals, CDC leadership chaos, and a worsening measles outbreak. They examine internal fractures within the Maha movement, the politicization of vaccine policy, and the devastating real-world consequences of misinformation — including a 7-year-old hospitalized with measles encephalitis. The episode blends policy critique, scientific context, and ethical concern, highlighting how regulatory instability and distrust are reshaping American public health in 2026. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

A edição de hoje destaca o I Fórum de Cirurgia Bariátrica e Metabólica do CFM, que discute estratégias para ampliar o acesso qualificado ao tratamento da obesidade no SUS. O boletim traz também o alerta do CDC sobre o aumento de casos graves e óbitos por influenza em crianças não vacinadas. Por fim, apresentamos a atualização da OMS sobre o surto multicêntrico de cólera, que mantém o risco global em nível muito alto. Acompanhe as notícias que impactam a gestão da linha de cuidado e a vigilância epidemiológica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/23-02-2026

In Belf's News Gallery, Greg Belfrage goes over the latest in trending news including Trump raising global tariffs, Men's US hockey winning gold at the Olympics, man with a gas can shot at Mar-A-Lago, Trump and the State of the Union, the CDC travel ban, Mike Huckabee and Tucker Carlson, a cartel leader was killed by the Mexican Federal Forces, and more...See omnystudio.com/listener for privacy information.

The down wing dry fly style is a perfect match for one of the most ubiquitous insects found in trout rivers across the planet: caddis. The down wing platform is also a first choice for matching many terrestrials, like moths and hoppers, and it finds it's way to stonefly patterns as well.But for this discussion, we cover the down wing and its progression into fly boxes, by looking at three standouts: the Elk Hair Caddis, the X-Caddis and the CDC & Elk. Because the arrival of each of these patterns brought forth major innovations to the world of dry flies. All three of these are down wings, but they are very different players on the water.The down wing, like all of these dry fly platforms, is a structural philosophy. There are reasons for having a wing that lays flat rather than stands up. The down wing is a canvas to be creative with. It starts with a wing that angles back.  Then, materials used for the undercarriage dictate how the fly behaves on the surface, along with where, when and how we expect trout to respond.My good friend, Bill Dell, joins me for a thorough look at another of our favorite fly platforms.ResourcesPODCAST: Troutbitten | Fly Tying - Essential Tools and More (S17 Ep9)READ: Troutbitten | Pattern vs PresentationPODCAST: Troutbitten | Fishing Dry Flies - Dry Fly Skills Series  (S12)VisitTroutbitten WebsiteTroutbitten InstagramTroutbitten YouTubeTroutbitten FacebookThanks to TroutRoutes:Use the code TROUTBITTEN for 20% off your membership athttps://maps.troutroutes.com Thanks to SkwalaUse the code, TROUTBITTEN10 for 10% off your order athttps://skwalafishing.com/

Granny flats are being sold as the answer to everything—housing affordability, rental yield, multigenerational living, even retirement planning. But once you get past the glossy numbers and council checklists, the reality is far more nuanced.In this episode, we sit down with Wally Gebrael, Co-Director at Granny Flat Solutions, to unpack what actually determines whether a granny flat works — and why so many builds quietly underperform. We break down the planning pathways (CDC vs DA), site constraints that kill feasibility, design mistakes that slash rental appeal, and the hidden costs investors rarely factor in.We also explore the bigger picture: how granny flats fit into Australia's housing crisis, why quality and layout directly impact yield, and when a granny flat can genuinely improve cash flow, versus when it simply ties up capital. Wally shares real-world examples from thousands of builds, including what separates high-performing granny flats from regret purchases.If you're considering building one — whether for family, flexibility, or investment — this episode will help you decide with clarity, not hype.Episode Highlights00:20 — Meet the Expert: Wally Gebrael03:12 — Financial Considerations and Value Addition06:18 — Challenges in Building Granny Flats08:44 — Council Regulations and Approval Process12:56 — Cost and Budgeting for Granny Flats23:59 — Designing Functional Spaces with a Wow Factor24:22 — Balancing Cost and Value for Investors and Homeowners25:37 — Optimal Granny Flat Designs29:52 — Impact of Interest Rates on Investments32:03 — Financial Considerations and Tax Implications37:57 — Common Mistakes in Granny Flat Projects43:43 — Final Thoughts and Listener QuestionsAbout the GuestWally Gebrael is the Co-Director at Granny Flat Solutions, one of Australia's leading specialists in secondary dwellings. Since establishing the business in 2011, Wally and his team have delivered more than 2,500 granny flats across NSW, navigating everything from straightforward CDC approvals to complex council applications involving flood zones, heritage overlays, and high-constraint sites.With over a decade at the coalface of design, approvals, and construction, Wally brings a grounded, practical perspective to the granny flat conversation. His insights aren't theoretical—they're based on real budgets, real rental outcomes, and the recurring mistakes homeowners and investors make when chasing “easy yield.”In a market saturated with oversimplified advice, Wally focuses on feasibility, function, and long-term performance—not sales-driven optimism.Connect with WallyWally's LinkedInGranny Flat Solutions' LinkedInGranny Flat Solutions' WebsiteGranny Flat Solutions' InstagramGranny Flat Solutions' Facebook

This year's Budget spotlights more ways to invest your CPF and how to deal with AI. Synopsis: Every first and third Monday of the month, get a head start in your personal finance, career and life with The Straits Times. Another year and another Budget speech, with goodies given out by PM Lawrence Wong. But is the Budget just about CDC vouchers and subsidies? What exactly is in it for young people? In this episode, ST business correspondent Sue-Ann Tan looks at what matters for young people in Singapore's Budget 2026. Her guests are DBS financial literacy expert Shawn Lee and OCBC executive director of wealth advisory Afdhal Rahman. Highlights (click/tap above): 2:00 How does the new investment scheme by CPF work? 4:58 What to consider before investing your CPF 11:00 SGX vs Nasdaq 14:30 AI as a central theme of the Budget 21:36 Are handouts of $200 to $400 enough for cost of living issues? 25:40 What do you want to see next in Budget 2027? Read Sue-Ann Tan's articles: https://str.sg/mvSa Follow Sue-Ann Tan on LinkedIn: https://str.sg/A86X Host: Sue-Ann Tan (suetan@sph.com.sg) Produced & edited by: Amirul Karim Executive producers: Ernest Luis, Lynda Hong & Joanna Seow Follow Headstart On Record Podcast channel here: Channel: https://str.sg/wB2m Apple Podcasts: https://str.sg/wuN3 Spotify: https://str.sg/wBr9 Feedback to: podcast@sph.com.sg Get business/career tips in ST's Headstart newsletter: https://str.sg/headstart-nl SPH Awedio app: https://www.awedio.sg --- Follow more ST podcast channels: All-in-one ST Podcasts channel: https://str.sg/wvz7 Get more updates: http://str.sg/stpodcasts The Usual Place Podcast YouTube: https://str.sg/theusualplacepodcast --- Get The Straits Times app, which has a dedicated podcast player section: The App Store: https://str.sg/icyB Google Play: https://str.sg/icyX --- Do note: All analyses, opinions, recommendations and other information in this podcast are for your general information only. You should not rely on them in making any decision. Please consult a fully qualified financial adviser or professional expert for independent advice and verification. To the fullest extent permitted by law, SPH Media shall not be liable for any loss arising from the use of or reliance on any analyses, opinions, recommendations and other information in this podcast. SPH Media accepts no responsibility or liability whatsoever that may result or arise from the products, services or information of any third parties. --- #headstartSee omnystudio.com/listener for privacy information.

There's a long-held idea that autism is more prevalent in boys than girls—the CDC says it's three times as common. But a growing body of research suggests the reality is more complicated. In a new study, researchers tracked autism diagnoses in millions of Swedish people born from 1985 to 2022. They found that the prevalence of autism is actually pretty even across the sexes, but people with “female” stamped on their birth certificate are often diagnosed later in life.  Host Flora Lichtman speaks with epidemiologist Caroline Fyfe about what this study teaches us about the prevalence of autism. Then, psychology researcher Rachel Moseley, an autistic woman herself, shares how late and missed diagnoses can affect autistic people. Guests: Dr. Caroline Fyfe is an epidemiologist at the University of Edinburgh who studied sex differences in autism diagnoses.  Dr. Rachel Moseley is a researcher in psychology at Bournemouth University in the UK, studying the experiences of autistic adults.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss reversal of last week's no review decision on a flu mRNA vaccine by Vinjay Prasad, appointment of Jay Bhattacharya as CDC director, no experience required, and already detectable reduction in hepatitis B virus vaccination rates, then Dr. Griffin then deep dives into recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, where to find PEMGARDA, how to access and pay for Paxlovid, the consequences of measles infection on immune amnesia (shout out to Immune 26), long COVID treatment center, where to go for answers to your long COVID questions, long COVID effect on fertility and type 2 diabetes and contacting your federal government representative to stop the assault on science and biomedical research.   Click arrow to play Download TWiV 1298 (26 MB .mp3, 43 min) Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Whiplash! F.D.A. Reverses Decision and Agrees to Review Moderna's Flu Vaccine (NY Times, Wall Street Journal, Access New wire) N.I.H. Director Will Temporarily Run C.D.C. in Leadership Shake-Up (NY Times) Reduction in infant Hepatitis B Immunizations (Oregon State Health Department) Why Adenovirus vectored vaccine failed: Adenoviral Inciting Antigen and Somatic Hypermutation in VITT (NEJM) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard(South Carolina Department of Public Health) Measles Outbreak Hits Florida College (NY Times) Utah's measles outbreak reaches 300 cases (CIDRAP) Measles Is Actively Spreading in SLCo (Salt Lake County Health Department) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Measles 2025 (NEJM) Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens (Science; Immune 26) Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles (Science) Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands (Nature Communications) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) The risk of cardiac disease events after respiratory syncytial virus disease: a systematic literature review and meta-analysis (European Respiratory Review) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) COVID-19 Antiviral Prescription Receipt Among Outpatients Aged ≥65 Years (CDC: MMWR) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Assessing the impact of SARS-CoV-2 infection and vaccination on fertility and assisted reproductive techniques outcomes: an umbrella review (Vaccine) Long-Term Risk of Incident Type 2 Diabetes Following SARS-CoV-2 Infection: A Population-Based Study in British Columbia, Canada (Diabetes Metabolism Research and Review) Reaching out to US house representative Letters read on TWiV 1298 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

The gap between vaccine science and vaccine policy has been widening under Health Secretary Robert F. Kennedy Jr. Now, the American Medical Association and the Vaccine Integrity Project, based at the University of Minnesota, have announced that they are partnering to create their own vaccine review process, effectively creating a parallel system to the CDC's. Host Ira Flatow talks with Michael Osterholm, executive director of the Vaccine Integrity Project, about the role of this new review panel.Guest: Dr. Michael Osterholm is the director of the Center for Infectious Disease Research and Policy and executive director of the Vaccine Integrity Project at the University of Minnesota.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Send Zorba a message!Zorba's thoughts on why measles (a virus we had nearly eradicated) is making a comeback, and how you can protect yourself and loved ones.(recorded February 19, 2026)Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

In this week's conversation between Dr. James Emery White and co-host Alexis Drye, they discuss a difficult subject that has so many nuances - suicide. And they prayed that they'd handle today's conversation delicately. The previous podcast episode - CCP183: On Counseling and Therapy - provided a segue to this subject since, along with the rise in those seeking counseling, there has also been a nationwide rise in the number of deaths caused by suicide. And the big question most often asked by those within the Christian faith is: Is suicide an unforgivable sin? Episode Links Dr. White shared some data from the CDC which found that from 2002 to 2022, the rates of suicide increased by 30%, and that in the year 2023, suicide became the 11th leading cause of death. As Dr. White noted, suicide is considered a form of murder - it is the killing of yourself - and violates one of the Ten Commandments. Dr. White gave a series at Mecklenburg Community Church called “Ten,” which looks at what the Bible says specifically about each of these commands from God. You can find that series on Church & Culture HERE. The conversation also explained the idea of apostasy - the act of abandoning one's faith. If you missed it, we'd encourage you to go back and listen to CCP131: On Losing Your Salvation. Another past podcast episode that is relevant for today's conversation is CCP48: On Medically Assisted Suicide. Finally, Alexis mentioned a book written by David Biebel and Suzanne Foster called Finding Your Way after the Suicide of Someone You Love: Help and Hope for an Unexpected Journey that many of our listeners may find helpful if they've lost someone to suicide. For those of you who are new to Church & Culture, we'd love to invite you to subscribe (for free of course) to the twice-weekly Church & Culture blog and check out the Daily Headline News - a collection of headlines from around the globe each weekday. We'd also love to hear from you if there is a topic that you'd like to see discussed on the Church & Culture Podcast in an upcoming episode. You can find the form to submit your questions at the bottom of the podcast page HERE.

Send Zorba a message!Zorba's thoughts on why measles (a virus we had nearly eradicated) is making a comeback, and how you can protect yourself and loved ones.(recorded February 19, 2026)Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

Episode 213: HIV PrEP Review H. Nicole Magaña, medical student, reviews the history of PrEP and outlines the currently FDA-approved medications used for HIV prevention. Dr. Arreaza provides additional perspective on long-acting injectable options, including how quickly they begin to protect patients after initiation.   Written by Nicole Magana, MSIV, American University of the Caribbean. Comments and edits by Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice. Pre-exposure prophylaxis for HIV. Previous episodes related to HIV:  -Episode 67, HIV history (September 2021) -Episode 68, HIV transmissibility (October 2021) -Episode 70 (October 2021), HIV prevention (including HIV Prep with oral medications) -Episode 98 (June 2022), we introduced Apretude, the first injectable for HIV PrEP. Apretude was approved in December 2021.  What is Pre-Exposure prophylaxis (PrEP)? Pre-exposure prophylaxis, or PrEP, is the use of antiretroviral medications taken by individuals who are HIV-negative to prevent HIV acquisition. There are 30,000 new HIV infections annually in the US.  How effective is it? When taken as prescribed, PrEP is highly effective at reducing the risk of HIV transmission through sexual exposure and injection drug use. Patients who are adherent to PrEP can lower their risk of contracting HIV by 99%. The effectiveness of oral PrEP is highly adherence dependent. In trials with 70% adherence, the relative risk of HIV acquisition was 0.27, compared to 0.51 with 40-70% adherence and no significant benefit with adherence ≤40%. How does PrEP work? PrEP works by maintaining therapeutic drug levels in the bloodstream and in target tissues. If HIV exposure occurs, viral replication is inhibited, preventing the establishment of infection. Brief History of PrEP. The concept of PrEP originated from early animal studies demonstrating that antiretroviral medications could prevent retroviral transmission when administered before exposure. In 2010, the iPrEx trial showed that daily oral tenofovir disoproxil fumarate (known as Truvada) with emtricitabine significantly reduced HIV acquisition among men who have sex with men and transgender women. This was the first large clinical trial to demonstrate the effectiveness of PrEP. In 2012, the FDA approved oral Truvada, which is TDF/FTC (tenofovir disoproxil and emtricitabine) for HIV prevention. Since then, additional studies have expanded indications and introduced new formulations, including long-acting injectable options. Who Should Be Offered PrEP? PrEP should be considered for any HIV-negative individual at increased risk of HIV acquisition, including Men who have sex with men, transgender individuals, heterosexual men and women with an HIV-positive partner, individuals with recent bacterial sexually transmitted infections, people who inject drugs, individuals engaging in condomless sex with partners of unknown HIV status. Remember that PrEP should be offered in a nonjudgmental, patient-centered manner, make it a safe space to talk openly about prevention of HIV.  Available HIV PrEP Options. Daily Oral PrEP: There are 2 formulations of Tenofovir. There is Tenofovir disoproxil fumarate (TDF)/ Truvada and Tenofovir alafenamide (TAF)/ Descovy. Each is available in a tablet combined with Emtricitabine a nucleoside reverse transcriptase inhibitor. Truvada: It is approved for all populations at risk through sexual exposure or injection drug use. Something to look out for before starting this medication is for pre-existing CKD. Do not give to patients who have an estimated glomerular filtration rate of less than 60 mL/min. (6) Descovy: This option is approved for men who have sex with men and transgender women but is not approved for individuals at risk through receptive vaginal sex. It has less impact on renal function and bone mineral density compared to Truvada. It can be used in moderately reduced kidney function (GFR between 30-60 mL/min). Truvada and Descovy are taken orally once a day.  After patients start taking these medications, when are they considered to be protected?  Nicole: With daily oral PrEP, guidelines differ with WHO and International Aids Society-USA stating it takes about 7 days, while CDC states 21 days to allow for adequate concentration in tissues (1). Adherence is critical for efficacy. Injectable HIV PrEP. In 2021, the FDA approved the first Injectable PrEP option Long-acting cabotegravir (CAB-LA)- known on the market as Apretude. Cabotegravir is an integrase strand transfer inhibitor administered as an intramuscular injection.Dosing consists of an initial injection, a second injection one month later, and then maintenance injections every two months (1). Another option is Lenacapavir (Yeztugo). The Yeztugo as a pre-exposure prophylaxis (PrEP) for HIV in Oct 2024. Yeztugo is the first and only FDA-approved HIV prevention treatment that requires just two injections per year, offering a long-acting option for people who weigh at least 35kg. It is given as 2 injections every 6 months. First dose is given with 2 tablets on Day 1 and Day 2, then every 6 months 2 injections on the same day. Clinical trials, including HPTN 083 and HPTN 084, demonstrated that injectable cabotegravir is superior to daily oral PrEP in preventing HIV infection. This advantage is largely due to improved adherence rather than differences in intrinsic drug potency. There have been no head-to-head comparisons between Yeztugo and Apretude, but they are both very effective. Apretude starts protecting 7 days after the first dose, and Yeztugo starts protecting 2 hours after Day 2 (if patient takes the oral loading dose) or 3-4 weeks if no oral load is taken. Injectable PrEP is particularly beneficial for patients who struggle with daily pill adherence, have trouble swallowing pills, prefer a discreet option, have difficulty storing their medication or have renal or bone disease that limits the use of tenofovir-based regimens like Truvada and Descovy (6). In one unpublished report by Medline, patients who received Apretude had an increase in bone mineral density compared to those who received Truvada (1). Tests prior to starting PrEP. Before initiating PrEP, patients must be confirmed to be HIV-negative. Baseline evaluation includes HIV testing with a fourth-generation antigen/antibody assay, HIV RNA testing if acute infection is suspected, renal function testing for oral PrEP, Hepatitis B screening, sexually transmitted infection screening, and pregnancy testing when appropriate. PrEP should not be started in individuals with known or suspected acute HIV infection. Monitoring for patients on HIV PrEP. Monitoring typically includes HIV testing every 2 to 3 months, STI screening every 3 to 6 months, renal function monitoring for those on oral PrEP (tenofovir- based), ongoing adherence and risk-reduction counseling. And for injectable PrEP, adherence to the injection schedule is essential, as delayed dosing may increase the risk of resistance if HIV infection occurs. HIV PrEP is not a prevention for other STIs. Screening for STIs and counseling about prevention is essential. Breakthrough HIV infections on PrEP are rare and most often associated with poor adherence or delayed diagnosis. Truvada is more studied in all populations and is considered safe during pregnancy and breastfeeding. There is less data regarding the injectable option in patients who are pregnant, may become pregnant, or whose primary risk factor is injection drug use (1). Injectable PrEP provides an important alternative for patients with chronic kidney disease and bone disease (1). Key Takeaway Pre-exposure prophylaxis is a safe, effective, and evidence-based strategy for HIV prevention. With both daily oral and long-acting injectable options available, PrEP can be individualized to meet patient needs. Normalizing PrEP discussions in clinical practice is essential to reducing new HIV infections and advancing public health goals.  Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!  References: Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel. The Journal of the American Medical Association. 2025. Gandhi RT, Landovitz RJ, Sax PE, et al. Long-Acting Lenacapavir Acts as an Effective Preexposure Prophylaxis in a Rectal SHIV Challenge Macaque Model. The Journal of Clinical Investigation. 2023. Bekerman E, Yant SR, VanderVeen L, et al. Pharmacokinetics and Safety of Once-Yearly Lenacapavir: A Phase 1, Open-Label Study. Lancet. 2025. Jogiraju V, Pawar P, Yager J, et al.

Patience Riley, LPC, PMH-C, is a perinatal mental health specialist who bridges the gap between clinical expertise and somatic wellness. With 14 years of experience as a Licensed Professional Counselor, Patience offers a multifaceted approach to healing by weaving together her roles as a therapist, RETAIN Parental Leave Coach, and 200 HR Registered Yoga Teacher specializing in prenatal care. Patience's career is defined by her work in high-impact settings, including psychiatric hospitals, crisis intervention, and military installations. As a military spouse, she brings a deeply personal understanding of the unique challenges facing service members and their families. Patience channels this dedication into her roles on the PSI Georgia Board and PSI Military Task Force, working to ensure every family—military and civilian alike—has access to the specialized support they deserve. In her private practice, Patience primarily supports clients during the perinatal period through individual therapy, yoga, and mental wellness workshops in her community. Her commitment to accessible mental health services and somatic healing is further reflected in her role leading PSI's Yoga for Pregnant & Postpartum Parents and her work as a member of the PSI Training Faculty and PSI's Alliance for People of Color. Patience has spoken for organizations such as the Wall Street Journal Podcast, the Policy Center for Maternal Mental Health, the Service Women Action Network, and the Maternal Mental Health Leadership Alliance. Her insights have been featured in Vanity Fair London and Vogue Singapore, and she was the cover story of Military Families Magazine. She has also contributed to the CDC's #HowRightNow campaign,  Military Spouse Magazine, and Wounded Warrior Project. Outside of her advocacy and clinical work, Patience is a creative, foodie, and ""plant mom"" who loves a good festival. She loves doing life with her college sweetheart and their two sons. Her Website Individual therapy: GA & NE residents Yoga: National & international www.whoamamas.com email: info@whoamamas.com Military Resources: Military OneSource: Support for Military Personnel & Their Families Military OneSource Counseling New Military Parent Specialty Consultation Military Family Life Counselor Program Postpartum Support International Military Resources and support group Telemynd: virtual mental health care MMHLA: Military, Veteran Women, and Maternal Mental Health Fact Sheet Military Reach: accessible and practical research for military families   CONNECT WITH DVORA ENTIN: Website: https://www.dvoraentin.com/ Instagram: https://www.instagram.com/dvoraentin YouTube: https://www.youtube.com/@misconceptionspodcast  

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of transformative events reshaping the industry landscape, from scientific breakthroughs to regulatory shifts and strategic corporate maneuvers.Let's start with Insmed's Brinsupri, a newly approved respiratory therapy that has captured attention with its projected $1 billion in sales by 2026. This ambitious forecast is grounded in Brinsupri's robust clinical efficacy and the increasing demand for innovative respiratory treatments. This development reflects a broader industry trend where targeted therapies are not only improving patient outcomes but also driving significant revenue growth. As respiratory conditions continue to be a major health challenge globally, the success of therapies like Brinsupri underscores the potential for innovation to meet these critical needs.In parallel, Merck is working strategically with its RSV antibody, Enflonsia, seeking a second-season approval to bolster its competitive stance against Sanofi and AstraZeneca's Beyfortus. The race in infant RSV prevention is intense as companies vie to establish dominance in this crucial segment of infectious disease management. Merck's efforts highlight the broader push within the industry to develop preventive measures that could significantly alter public health landscapes by reducing the incidence of severe respiratory illnesses in vulnerable populations.Meanwhile, regulatory scrutiny remains a constant for pharmaceutical companies. The FDA's recent review of Johnson & Johnson's advertising for Tremfya, targeting ulcerative colitis, emphasizes the agency's commitment to ensuring that efficacy claims are both truthful and transparent. This serves as a reminder of the importance of maintaining regulatory compliance and ethical advertising practices within the industry—a critical aspect as companies navigate complex marketing landscapes while ensuring patient trust.Shifts in leadership within key health organizations are also noteworthy. Jay Bhattacharya stepping into the role of acting CDC chief after Jim O'Neill's departure could signal changes in public health policy and research priorities. Such transitions can have profound effects on how emerging health challenges are addressed, potentially influencing everything from vaccine distribution strategies to research funding allocations.As we turn to policy discussions, President Donald Trump's most favored nation drug pricing proposal continues to stir debate. This initiative aims to lower drug prices by benchmarking them against international rates, but it faces resistance from free-market advocates who argue it could stifle pharmaceutical innovation. The ongoing discussion around drug pricing reform is pivotal, as it impacts both patient access to medications and the incentives for companies to invest in new drug development.Strategic realignments in the contract development and manufacturing organization (CDMO) sector are also making headlines. Recipharm's sale of its Israeli API plant to Scinai Immunotherapeutics, alongside a new CDMO partnership, illustrates how companies are optimizing resources to focus on core competencies and expand service offerings. This strategic shift highlights the dynamic nature of CDMOs as they adapt to changing market demands and technological advancements.In Alzheimer's research, there's promising news with a study suggesting that a blood test could predict when symptoms will appear, representing a significant leap forward in early diagnosis and intervention strategies. These advancements offer hope for altering the treatment landscape of neurodegenerative diseases through timely therapeutic interventions that could improve quality of life for patients. However, challenges remain as seen with Johnson & Johnson pausing enrollment in itsSupport the show

Half of states have rejected federal vaccine guidance on childhood vaccines after controversial changes by the CDC. Public health experts say the split is sowing confusion and increasing the risk of outbreaks. Guests:Michelle Fiscus, physician, chief medical officer, Association of Immunization ManagersJen Kates, senior vice president; director, global and public health policy, KFF Tao Sheng Kwan-Gett, physician, health officer, Washington Department of HealthPhilip Landrigan, physician and director, program for global public health and the common good, Boston College Dorit Reiss, law professor, University of California, San FranciscoLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Eight skiers have been found dead, and one is still missing, a day after an avalanche hit the Sierra Nevada near Lake Tahoe. The sheriff's office says six survivors were rescued with “various injuries,” two of whom were transported to the hospital for treatment.In the largest military buildup yet in the Middle East, President Donald Trump is sending the USS Gerald R. Ford to the Mediterranean, along with a large fleet of fighter jets and aerial refueling tankers. This comes as negotiations between the United States and Iran continue, with Trump making his demands clear to the Iranian regime—no nuclear weapons and stop killing anti-regime protesters.The director of the National Institutes of Health is taking on an additional role. According to the White House on Wednesday, Dr. Jay Bhattacharya will serve as acting director of the CDC until a permanent nominee is confirmed.

Few issues have tested public trust in medicine as deeply as vaccines, and few individuals have influenced that dialogue more than Dr. Paul Offit, director of the Vaccine Education Center at the Children's Hospital of Philadelphia and a longtime member of the FDA's Vaccine Advisory Committee. In this timely and candid interview with Raise the Line host Lindsey Smith, Dr. Offit points to this year's severe flu season and a resurgence of measles as alarming proof points of how a changing federal perspective on vaccine policy is having a real impact on public health. “You'd like to think you can educate about the importance of vaccines, but I fear at this point the viruses themselves are doing the educating.” In this wide ranging discussion, Dr. Offit also addresses: The rigorous and painstaking process of developing vaccines, based on his experience co-inventing the rotavirus vaccine. Shifting levels of public trust in scientific organizations. Promising innovations in vaccine development. Don't miss this deeply-informed perspective on the interplay of science, policy, and public education, and his encouraging message to young clinicians about managing the current challenges in public health.  Mentioned in this episode: Vaccine Education Center at Children's Hospital of PhiladelphiaPerelman School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Tonight on NJ Spotlight News, an ongoing debate over an immigration detention facility in Roxbury has been creating confusion among state and local leaders.   Plus, the funding has been restored, but has work started back up at the Gateway Tunnel project? We'll talk to the head of the Gateway Development Commission.   Also, we get the latest from the State House on a series of bills aimed at protecting immigrant rights.   And, from vaccine rates, to CDC changes and a possible new flu vaccine, we'll get you the latest from a health expert. 

Internal admissions from CDC and EPA show agreement with findings that fluoride causes brain damage in animal studies. #FluorideRisk #CDCAdmissions #Neurodamage #BrainToxins

Trump sought $163 billion in cuts, including slashing the EPA by 54 percent, HUD by 44 percent, and the CDC by 41 percent, but even his most loyal House allies let the effort stall under the cover of the budget process. A separate bipartisan attempt to shore up Obamacare subsidies for 24 million Americans also fizzled, with Rep. Brian Fitzpatrick warning that letting them lapse would be bad policy and worse politics. The throughline is inertia: Congress will not enact maximalist right-wing cuts, but it will not pass incremental fixes either. Plus, a handoff to the debut of How To!: "How to Be a DJ, Not a Playlist," featuring the DJ with hooks for hands, Tom Nash, on craft, resilience, and commanding a room. Produced by Corey Wara Video and Social Media by Geoff Craig Do you have questions or comments, or just want to say hello? Email us at ⁠⁠⁠⁠thegist@mikepesca.com For full Pesca content and updates, check out our website at https://www.mikepesca.com/ ⁠For ad-free content or to become a Pesca Plus subscriber, check out ⁠⁠⁠⁠https://subscribe.mikepesca.com/ For Mike's daily takes on Substack, subscribe to The Gist List https://mikepesca.substack.com/ Follow us on Social Media:⁠⁠⁠⁠ YouTube https://www.youtube.com/channel/UC4_bh0wHgk2YfpKf4rg40_g⁠⁠⁠⁠ Instagram https://www.instagram.com/pescagist/ X https://x.com/pescami TikTok https://www.tiktok.com/@pescagist To advertise on the show, contact ⁠⁠⁠⁠ad-sales@libsyn.com⁠⁠⁠⁠ or visit ⁠⁠⁠⁠https://advertising.libsyn.com/TheGist

In our news wrap Wednesday, the National Institutes of Health Director Dr. Jay Bhattacharya will serve as acting head of the CDC, the FDA reversed its decision to consider whether to approve a new mRNA flu shot from Moderna and billionaire Les Wexner told lawmakers he was "duped by a world-class con-man" as he faced questions about his association with Jeffrey Epstein. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Wednesday, February 18, 2026 In this episode: The White House installed a critic of the CDC as the acting director of the CDC; the U.S. and Iran both claimed they've made “progress” in during latest nuclear talks even as the U.S. military is preparing for a possible strike on Iran as early as this weekend; Trump's top economic adviser said New York Federal Reserve staffers should be “disciplined” for a study concluding that Americans paid nearly 90% of the costs of Trump's tariffs; FCC Chair Brendan Carr denied censoring CBS after Stephen Colbert said network lawyers blocked an interview with Texas Democratic Senate candidate James Talarico; at least 12 Democrats said they will boycott Trump's State of the Union next week; and 70% of Democrats have a positive view of the Democratic Party – down from 85% in September 2024. Read more: Day 1856: "An embarrassment." Newsletter: Get the daily edition of WTFJHT in your inbox Feedback? Let me know what you think AI Policy: My AI policy

What do infection prevention in dialysis clinics and hurricane response in the Caribbean have in common? More than you might think. This episode explores how culture, leadership, and coordination shape health outcomes, whether in a treatment chair or a disaster zone. First, Shalini Nair, a Senior Analyst of Infection Disease at ASTHO, breaks down the growing concern around dialysis-related infections and what the CDC's Making Dialysis Safer for Patients Coalition is doing to address it. She shares frontline-informed strategies that health departments and facilities can use right now: building a “see it, say it” culture of safety, using short, role-specific training and real-time coaching, and ensuring visible leadership support that reinforces infection prevention as everyone's responsibility.  Then, the focus shifts to disaster response with Maggie Nilz, Senior Analyst of preparedness at ASTHO and Team Rubicon, a veteran-led humanitarian organization. Nilz reflects on her decade of deployments, from chainsaw operations in U.S. disaster zones to coordinating international health response in Jamaica after a devastating hurricane. She explains how public health leadership, interagency coordination, and pre-disaster data systems are critical when hospitals are damaged, infrastructure is down, and communities still need everyday healthcare. Key Insights to Improve Infection Prevention in Dialysis Settings | ASTHOMeeting Home PageLeading Humanitarian Aid Organization in the US | Team RubiconLeadership Power Hour: Your Launchpad for Impact | ASTHOMeeting Home Page

Music reaches your brain fast! It activates memory, movement, emotion, and connection in seconds.In this episode, host Dr. Krystal L. Culler, DBH, MA, sat down with Shannon Wallace, CDP, CDC, creator of Musical Memory Care to explore how music functions as a whole-brain and body workout. We focus on one powerful idea—the “time of your life” effect.Research shows the music you loved between roughly ages 13 and 27 leaves a lasting imprint. Those songs shape identity. They anchor memory. They often remain accessible even during cognitive change.Shannon shares how she moved from professional jazz vocalist to serving older adults in memory care communities. What began as singing for residents evolved into an intentional, research-informed program that integrates rhythm, movement, emotional expression, and identity support.We explore:Why time-of-life music remains accessible in dementia How music activates the limbic system and supports emotional regulation The role of rhythm in movement, including Parkinson's support Why intentional facilitation matters in memory care settings How music supports dignity, identity, and human connection Practical ways you can use music today for brain healthYou will hear real-world stories from Shannon's work in memory care. Stories of individuals who had not spoken in years yet responded to music. Stories of rhythm supporting walking and daily tasks. Stories that reinforce this truth. Music is not entertainment alone. It is a neurological tool.If you are a caregiver, clinician, or family member supporting someone with cognitive change, this conversation gives you some practical suggestions. Play their music, not yours. Use rhythm to support movement. Build playlists rooted in their adolescence and young adulthood. Intention matters.If you are focused on your own brain health, start here:Create a “time of your life” playlist Use music to regulate mood and stress Pair rhythm with movement for exercise Share meaningful songs to deepen social connectionMusic does not require perfection. It asks for presence.About Shannon Wallace, CDP, CDC Shannon Wallace is a professional international jazz vocalist and the creator of Musical Memory Care, an interactive program serving active older adults and individuals living with all stages of dementia. Her work has reached participants across North America and in more than 40 countries. She is a Certified Dementia Practitioner and Dementia Care Certified professional who integrates music, movement, and compassion into structured memory care experiences.Brain health lives in daily moments. Music is one of the most accessible tools you already have.00:00 Why Music Hits Fast: A Whole Brain + Body Workout00:49 Meet Shannon Wallace & the Musical Memory Care Mission02:23 The Grant Question That Changed Everything (Volunteering in Memory Care)05:48 Music Like Fitness: Intentionality, Regulation, and Engagement08:09 Your “Time of Life” Music Bump: Why Certain Songs Stick Forever11:41 Music for Mood & Nervous System Regulation (Limbic System, Empathy, Shifting State)15:10 Why Music Still Connects in Dementia—and the Need for Intentional Care20:45 Inside the Musical Memory Care Program: Reading the Room + Multi-Sensory Design23:32 Proof in Practice: Vivian Speaks Again & Building Trust Through Personal Connection29:28 Try This at Home: Playlists, Movement, Sharing Songs + Parkinson's Rhythm Hack36:24 Closing Wisdom: Work-Life Balance, Where to Find Shannon, and Final TakeawaysResourcesDownload the free infographic on how music is a whole brain-body workout!Learn more about Shannon and her Musical Memory Care™ program on her website. Connect with Shannon on LinkedIn or her professional website for her vocal talent or speaking.Listen to our previous podcast conversation with Eyleen Braaten, Executive Director of the Giving Voice Chorus and Neuroscientist, Dr. Patricia Izbicki, Ph.D., to learn how singing can impact your brain. 

Last week, the FDA declined to review Moderna's mRNA-based flu vaccine, with Center for Biologics Evaluation and Research Director Vinay Prasad himself signing the refuse-to-file (RTF) letter. Prasad said Moderna's comparator group “does notreflect the best-available standard of care,” while Moderna pushed back, saying CBER had previously found a standard-dose flu shot to be an “acceptable” comparator. Despite the shocking turn of events, HHS backed Prasad, saying Moderna didn't “follow very clear FDA guidance from 2024.”Regardless of the reasons, the development imperilsModerna's breakeven plans, affecting not just the company's investigational flu vaccine but also a flu-COVID combo shot and other parts of the company's pipeline. And for the broader industry, it highlights the regulatory uncertainty that persists into 2026, even as other countries move full speed ahead with novel modalities.That regulatory uncertainty extended this week to DiscMedicine, whose rare disease drug bitopertin was rejectedby the FDA. The company tried to convince investors that its planned Phase 3 trial would pave the way toward a refiling, but analysts raised concerns that the study was developed with oldFDA leadership. Disc's situation also raises questions about the FDA's Commissioner's National Priority Voucher, which bitopertin had received.Meanwhile, Compass Pathways dropped long-awaited data from two Phase 3 trials of its psilocybin-based COMP360, showing strong durability data that “clearly met the Street's bar for success,” according to Stifel analysts. The company plans to complete a rolling new drug application by the end of the year.Finally, the CDC has been left leaderless, again, with the departure of Jim O'Neill, who had been servingas acting director after the ouster of Susan Monarez last summer. And Sanofi's Paul Hudson was removed as CEO last week. He'll be replaced by Merck KGaA's Belén Garijo, who becomes just the second woman in charge of a Big pharmacompany.

Transforming your health is more fun with friends! Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ ORDER MY NEW BOOK SWEET INDULGENCE!!! https://www.amazon.com/Chef-AJs-Sweet-Indulgence-Guilt-Free/dp/1570674248 or https://www.barnesandnoble.com/w/book/1144514092?ean=9781570674242 MY BEST SELLING WEIGHT LOSS BOOK: https://www.amazon.com/dp/1570674086?tag=onamzchefajsh-20&linkCode=ssc&creativeASIN=1570674086&asc_item-id=amzn1.ideas.1GNPDCAG4A86S Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. Please get the book here now! To get a copy signed by Dr. Goldhamer: https://www.healthpromoting.com/can-fasting-save-your-life To buy on Amazon: https://www.amazon.com/dp/1570674191?linkCode=ssc&tag=onamzchefajsh-20&creativeASIN=1570674191&asc_item-id=amzn1.ideas.1GNPDCAG4A86S&ref_=aip_sf_list_spv_ofs_mixed_d_asin Dr. LIsle and Dr. Goldhamer's book The Pleasure Trap: https://www.amazon.com/dp/1570671974?tag=onamzchefajsh-20&linkCode=ssc&creativeASIN=1570671974&asc_item-id=amzn1.ideas.1GNPDCAG4A86S Dr. Alan Goldhamer is the co-founder of TrueNorth Health Center, a state-of-the-art facility that provides medical and chiropractic services, psychotherapy and counseling, as well as massage and bodywork. He is also director of the Center's groundbreaking residential health education program. Dr. Goldhamer has supervised the fasts of thousands of patients. Under his guidance, the Center has become one of the premier training facilities for doctors wishing to gain certification in the supervision of therapeutic fasting. Dr. Goldhamer is speaking at the NHA Virtual Conference (June 27-30, 2024). Use this link to get your tickets now: https://events.ringcentral.com/events/nha-conference-2024/registration?utm_campaign=Chef+AJ&utm_source=Affiliate For coaching services: https://www.healthpromoting.com/clinic-services/health-services/coaching-services To register for a stay at TrueNorth: https://www.healthpromoting.com/registration Dr. Toshia Myers is a clinical biologist and the Director of the TrueNorth Health Foundation (TNHF). Under her leadership, TNHF has developed a pioneering research and training program that conducts clinical trials investigating the real-world effects of prolonged water-only fasting followed by a whole-plant-food diet on human health. She is the co-author of over 20 peer-reviewed articles on prolonged water-only fasting, along with numerous popular articles, a textbook chapter, and the book Can Fasting Save Your Life? Dr. Myers holds a Ph.D. in Biological Sciences from Columbia University and completed postdoctoral fellowships in immunology at the CDC and epigenetics at BRIC. An advocate of natural living, she enjoys spending time with her family among the oaks and redwoods of Northern California. Her own experiences with prolonged water-only fasting have deepened her awareness of the body's innate ability to heal and enhanced her overall well-being in a way that is not easily quantified. She encourages anyone who can safely fast to explore this potentially life-changing experience. https://www.ncbi.nlm.nih.gov/myncbi/toshia.myers.2/bibliography/public/ https://www.healthpromoting.com/store/book/can-fasting-save-your-life https://www.fasting.org

Lab work and field reports begin to line up. The CDC team confirms that the outbreak isn't a mutation or a known virus...it's something entirely new: Spasov Hudson's Disease. Hosted on Acast. See acast.com/privacy for more information.

Erica Jiminez went from facing a potential layoff at the CDC to landing her dream role as the first-ever User Experience Officer at WK Kellogg Foundation. In this episode, Sarah Doody chats with Erica about her experience in Sarah's UX job search coaching program, Career Strategy Lab.Erica shares how she got clear on what she wanted, made sense of a non-linear career path, and landed a mission-driven UX role.Erica talks about how the Career Roadmap and Compass Statement in Career Strategy Lab helped her shift from a fear mindset to clarity, why her "messy" career path across social work, public health, and UX research actually became her biggest strength, and how she got hired using a whiteboard and Mural board instead of a polished portfolio. She also shares why she negotiated her salary and got what she asked for, and what hiring managers actually look for when multiple candidates are equally qualified.Erica's 3 lessons from her UX job search:1) Follow what you're passionate about2) Go for it even if you're not ready3) Know your worth and advocate for yourself — the worst they can say is noTimestamps0:00 Introduction 1:00 Meet Erica, the first UX Officer at WK Kellogg Foundation 3:00 The career roadmap: realizing how unintentional her career had been 4:30 From social worker to UX researcher — a 12-year non-linear path 5:00 Seeing the story in a "messy" resume 7:00 The Product of You: Design yourself before marketing yourself 8:00 Getting clarity vs. jumping straight to tactics10:00 The Gumby mindset & reframing your experiences12:00 Lesson 1: Follow what you're passionate about13:00 Lesson 2: Go for it even if you're not ready 15:00Lesson 3: Know your worth & salary negotiation17:00 The heroes exercise & discovering what matters beyond UX19:30 Applying UX skills beyond big tech20:00 Advice for anyone on the fence about Career Strategy Lab22:00 Why the human element matters most in hiring

In this episode of The Clay Edwards Show, host Clay Edwards kicks off a high-energy Monday with unfiltered takes on current events and cultural issues. He dives into his weekend discoveries, including a deep dive into the Angel Studios app and a strong recommendation for the eye-opening documentary "Thank You, Dr. Fauci," which exposes controversies around COVID origins, vaccines, and cover-ups featuring insights from scientists, journalists, and former CDC leaders. Clay also shares thoughts on the post-apocalyptic film "Homestead" and its series spin-off, praising their relevance to real-world prepping scenarios.   A caller weighs in on methane facts and corruption in Mississippi courts, sparking a discussion on statewide issues. Clay tackles timely stories like Amazon ending its partnership with surveillance company Ring amid privacy concerns, the final closure of Chrishell's restaurant, a bizarre video from Savannah Guthrie about her mother, a viral brawl at La Cazuela in Jackson leading to city scrutiny, and an update on a tragic incident involving a former JA student. He highlights positive education news with Mississippi, Alabama, and Louisiana leading post-COVID gains in reading and math scores.   The episode explores intriguing connections, like SpongeBob SquarePants' address linking to Epstein Island and the Nickelodeon logo's eerie resemblance to it. Clay delves into generational politics, questioning why Gen X has been sidelined in leadership roles and urging more involvement to counter boomer dominance. Strap in for raw commentary on cancel culture, conservative values, and America's future—unfiltered and no holds barred.

In the first hour of episode #1156, Clay Edwards fires up your Monday with raw motivation to rise, grind, and conquer the week. He shares his weekend highlights, including subscribing to the Angel Studios app for faith-based and conservative-leaning content, and highly recommends the must-watch documentary "Thank You, Dr. Fauci," unpacking COVID conspiracies, lab leaks, vaccine funding, and money-driven cover-ups with insights from scientists, journalists, and a former CDC head. Clay also dives into the post-apocalyptic thriller "Homestead" and its series, tying into real-world prepping discussions. A caller chimes in on methane facts and Mississippi court corruption, sparking thoughts on statewide issues. Teasing upcoming headlines like Amazon's Ring split, a Jackson restaurant brawl, education wins, and eerie Epstein Island links to SpongeBob. Plus, a fiery take on a Maryland school official reporting conservative teens to child services for starting a TPUSA club, exposing left-wing indoctrination fears. Unfiltered rants on liberal hysteria, SSRIs, and generational politics round out the hour—strap in for no-holds-barred reality radio.

In this powerful episode of The Lebanese Physicians Podcast, we sit down with Dr. Rana Hajjeh, a global public health leader whose career has spanned over three decades at the heart of epidemic response, vaccine policy, and global health diplomacy. From her early training as an Epidemic Intelligence Service (EIS) officer at the CDC to leading outbreak responses to meningitis, Ebola, MERS, and COVID-19, Dr. Hajjeh reflects on what it truly means to work at the frontlines when science, uncertainty, and urgency collide. She shares behind-the-scenes insights into global vaccine introduction, lessons on equity and trust, and why global coordination through organizations like the WHO remains indispensable in a world without borders. This conversation goes beyond titles and institutions exploring leadership, resilience, and the human side of public health decision-making. Whether you're a physician, public health professional, policymaker, or simply curious about how global health works in real life, this episode offers rare perspective, hard-earned wisdom, and enduring hope for the future.

What’s Trending: The show trial impeachment ended over the weekend, and Western Washington gets pounded by snow. Seattle businesses continue to leave the city, will Durkan and company do anything to stop it? CDC’s new guidelines to reopen schools follow exactly what teacher unions are demanding.

In "The Bells Still Ring," Dr. Osterholm and Chris Dall discuss a recent poll on Americans' trust in vaccine information from the CDC, the measles outbreaks in immigration detention centers, and explain the controversy over a US-funded hepatitis B vaccine trial in Africa. Dr. Osterholm will also bring you some good news on US funding for global health and answer an ID Query about Nipah virus.Interactive vaccine map for US schools (Washington Post)  Large share of older US adults haven't had a recent flu or COVID vaccine, poll finds (CIDRAP News)Two cases of tuberculosis detected at El Paso ICE facility (The Texas Tribune)  Detained Immigrants Detail Physical Abuse and Inhumane Conditions at Largest Immigration Detention Center in the U.S. (ACLU)  ‘No Humanity': Detainees describe conditions inside Whipple Federal Building (The Star Tribune)     Resources for vaccine and public health advocacy: Voices for Vaccines Families Fighting Flu Vaccinate Your Family Shot@Life Medical Reserve Corps Learn more about the Vaccine Integrity Project MORE EPISODES       SUPPORT THIS PODCAST   Music: "Beauty Flow" Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 4.0 License